企業プロフィール
Nanobiotix 株価・ニュース・カタリスト
- ティッカー:
- NBTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- France and listed in the U
株価パフォーマンス
43.68 USD (-3.77%)
終値
最終更新: 2026年8月20日
1.86B USD
時価総額
株価変動の要因
As of Aug 20, 2026, NBTX closed down 3.77% at $43.68. No new same-company headline was identified in the current news window.
企業概要
事業概要
Nanobiotix is a radiotherapy and oncology company focused on nanoparticle-enabled cancer treatment. Its platform is built around improving how radiation interacts with tumors.
所在地とセクター分類
Headquartered in France and listed in the U.S. as an ADR, Nanobiotix has a global oncology-biotech profile.
ビジネスモデルの特徴
The business depends on clinical data, regulatory progress, and the ability to translate nanoparticle science into cancer value.
バイオ業界での位置付け
Nanobiotix is a catalyst-driven oncology name whose stock reacts strongly to development and partnership updates.
今後のカタリスト
- Nanobiotix’s catalysts are its radioenhancer platform and any oncology update that shows the technology can improve local control without unacceptable toxicity. The market will care about whether the platform continues to look clinically relevant.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。